Revisions Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Real-time Estimate Cboe BZX 18:09:35 28/05/2024 BST 5-day change 1st Jan Change
22.56 USD -5.76% Intraday chart for Enliven Therapeutics, Inc. -1.81% +62.46%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. Revisions Enliven Therapeutics, Inc.